At Ipsen, we are committed to improving patients’ lives. With over 90 years of experience, we focus our energy on developing and commercializing new therapeutic options in oncology, neuroscience, and rare diseases. The patients we serve live with serious and rare diseases, and our end goal is to ensure that we provide innovative medicines to help –
A career with Ipsen is about improving patients’ lives. In every department, our high-performing teams are dedicated to making a difference in our three therapeutic areas: oncology, neuroscience and rare diseases. With total sales close to €2.576 billion in 2019, Ipsen markets more than 20 drugs in over 115 countries with a direct commercial presence in 37 countries. Our R&D focus is on developing innovative medicines that address unmet patient needs in the areas of oncology, neuroscience and rare diseases. To do this, we placed our main R&D centers in the world-class scientific hubs of Paris-Saclay, France, Oxford, United Kingdom, and Cambridge, United States. This allows us to take advantage of critical networking opportunities and to progress our external innovation philosophy within established scientific ecosystems.